Tag: MC2 Therapeutics

All

Popular

FDA Approves Wynzora Cream for Adults with Plaque Psoriasis

The US Food and Drug Administration (FDA) has approved Wynzora Cream (calcipotriene and betamethasone dipropionate, w/w 0.005%/0.064%) for once-daily topical treatment of plaque psoriasis in adults 18 years of age or older, MC2 Therapeutics announces.

All

Latest
Sorry, No Posts Found

All

Popular
Sorry, No Posts Found
Sorry, No Posts Found